Agilent Technologies, Inc. $A Shares Acquired by Handelsbanken Fonder AB

Key Points

• Handelsbanken Fonder AB increased its Agilent Technologies stake by 34.4% in the second quarter, adding 41,536 shares to hold 162,195 shares valued at approximately $21.5 million.
• Analysts maintain a generally positive outlook, with Agilent receiving a consensus “Moderate Buy” rating and an average price target of $160.24.
• Agilent reported quarterly EPS of $1.49, exceeding estimates by $0.08, while revenue rose 10% year over year to $1.83 billion. The company also paid a quarterly dividend of $0.255 per share, representing a 0.7% yield.

Handelsbanken Fonder AB grew its holdings in Agilent Technologies, Inc. (NYSE:A - Free Report) by 34.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 162,195 shares of the medical research company's stock after purchasing an additional 41,536 shares during the quarter. Handelsbanken Fonder AB owned 0.06% of Agilent Technologies worth $21,544,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Revolve Wealth Partners LLC acquired a new stake in Agilent Technologies during the 2nd quarter worth approximately $320,000. Dudley & Shanley Inc. boosted its position in Agilent Technologies by 25.9% in the 2nd quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company's stock valued at $9,232,000 after buying an additional 14,300 shares during the period. Chesley Taft & Associates LLC grew its stake in shares of Agilent Technologies by 4.1% in the second quarter. Chesley Taft & Associates LLC now owns 9,486 shares of the medical research company's stock worth $1,260,000 after acquiring an additional 372 shares in the last quarter. Cooper Financial Group grew its stake in shares of Agilent Technologies by 17.0% in the second quarter. Cooper Financial Group now owns 2,771 shares of the medical research company's stock worth $368,000 after acquiring an additional 402 shares in the last quarter. Finally, Elevation Wealth Partners LLC increased its position in shares of Agilent Technologies by 7.5% during the second quarter. Elevation Wealth Partners LLC now owns 4,536 shares of the medical research company's stock worth $603,000 after acquiring an additional 315 shares during the period.

Wall Street Analyst Weigh In

A has been the subject of a number of recent research reports. Piper Sandler initiated coverage on Agilent Technologies in a report on Thursday, June 11th. They issued a "neutral" rating and a $150.00 target price for the company. HSBC cut their price target on Agilent Technologies from $180.00 to $165.00 and set a "buy" rating on the stock in a report on Wednesday, June 3rd. TD Cowen increased their price target on Agilent Technologies from $147.00 to $155.00 and gave the company a "buy" rating in a research report on Thursday, May 28th. Bank of America upgraded Agilent Technologies from a "neutral" rating to a "buy" rating and decreased their price objective for the company from $150.00 to $145.00 in a research note on Thursday, May 28th. Finally, Wells Fargo & Company lowered their price objective on Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating for the company in a research report on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $160.24.

Agilent Technologies Stock Performance

Shares of A stock opened at $148.28 on Thursday. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The firm has a fifty day moving average price of $134.90 and a 200 day moving average price of $125.30. The company has a market cap of $41.88 billion, a P/E ratio of 29.78, a PEG ratio of 2.65 and a beta of 1.25. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $160.27.

Agilent Technologies (NYSE:A - Get Free Report) last posted its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. The firm had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.Agilent Technologies's revenue for the quarter was up 10.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts predict that Agilent Technologies, Inc. will post 6.03 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were given a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, June 30th. Agilent Technologies's dividend payout ratio (DPR) is 20.48%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source